Kanjanapan Y, Yip D. Considerations for cancer immunotherapy during the COVID‐19 pandemic. Med J Aust 2020; 213: 390‐392. https://doi.org/10.5694/mja2.50805
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
Correspondence:
Online responses are no longer available. Please refer to our instructions for authors page for more information.

